US Pharm. 2009;34(5):36-38. 

Prasco Laboratories, headquartered in Mason, Ohio, has entered into a marketing and distribution agreement with GlaxoSmithKline (GSK) to market Flonase (fluticasone propionate) nasal spray, the first product to be marketed under the new agreement. Prasco, as GSK's agent and on GSK's behalf, will solicit orders for and distribute fluticasone propionate nasal spray to all trade classes in the U.S. under a GSK/Prasco label.